Linked e-resources
Details
Table of Contents
Acknowledgements; Contents; Contributors; General Principles; 1 Introduction; Epidemiology; Signs and Symptoms; Classification of Uveitis; References; 2 Approach to the Laboratory, Imaging, and Molecular Work-up for Uveitis; Introduction; Goal of Testing; Nomenclature and Classification; The Importance of History and Examination; Principles of Diagnostic Testing; Individual Tests; Laboratory; Tuberculin Skin Test and Interferon Gamma Release Assays; Syphilis Testing (Non-specific and Specific); Lyme Testing; Angiotensin Converting Enzyme and Lysozyme
Antinuclear Antibodies and Rheumatoid FactorLess Frequently Used Laboratory Tests; Molecular; HLA-Typing; Imaging; Chest X-Ray; Chest Computed Tomography; Magnetic Resonance Imaging; Tissue Sampling; Polymerase Chain Reaction; Biopsy/Cytology; Suggested Testing Algorithm by Anatomic Classification; Posterior and Panuveitis; Testing for Masquerade Syndromes; Tests of Limited Utility and Additional Testing; Conclusion; References; Causes-Infectious Uveitis; 3 Bartonella; Introduction; Epidemiology; Clinical Manifestations; Diagnosis; Treatment; Conclusion; References; 4 Candida; Introduction
Clinical ManifestationsDiagnosis; Treatment; Conclusion; References; 5 CMV Retinitis; Introduction; Clinical Presentation; Diagnosis; Treatment; CMV Retinitis in the Era of HAART; Complications Related to CMV Retinitis; Retinal Detachment in CMV Retinitis; Immune Recovery Uveitis; Conclusion; References; 6 Herpes Simplex and Herpes Zoster; Anterior Segment Disease; Herpes Simplex Virus; Treatment; Varicella Zoster Virus; Treatment; Posterior Segment Disease; Acute Retinal Necrosis; Clinical Presentation; Treatment; Progressive Outer Retinal Necrosis; Clinical Presentation; Treatment Options
IndicationsLaser Therapy; Surgery; Steroids; Anti-VEGF Agents; Prognosis; Prevention; Conclusion; References; 11 Rubella; Introduction; Epidemiology; Clinical Manifestations; Diagnosis; Treatment; Conclusion; References; 12 Syphilis; Introduction/Clinical Features; Epidemiology; Diagnostic Evaluation; Treatment and Monitoring; Prognosis; References; 13 Ocular Toxocariasis; Introduction; Epidemiology; Clinical Manifestations; Diagnosis; Treatment; Conclusion; References; 14 Ocular Toxoplasmosis; Introduction; Etiology; Epidemiology; Clinical Presentation
Antinuclear Antibodies and Rheumatoid FactorLess Frequently Used Laboratory Tests; Molecular; HLA-Typing; Imaging; Chest X-Ray; Chest Computed Tomography; Magnetic Resonance Imaging; Tissue Sampling; Polymerase Chain Reaction; Biopsy/Cytology; Suggested Testing Algorithm by Anatomic Classification; Posterior and Panuveitis; Testing for Masquerade Syndromes; Tests of Limited Utility and Additional Testing; Conclusion; References; Causes-Infectious Uveitis; 3 Bartonella; Introduction; Epidemiology; Clinical Manifestations; Diagnosis; Treatment; Conclusion; References; 4 Candida; Introduction
Clinical ManifestationsDiagnosis; Treatment; Conclusion; References; 5 CMV Retinitis; Introduction; Clinical Presentation; Diagnosis; Treatment; CMV Retinitis in the Era of HAART; Complications Related to CMV Retinitis; Retinal Detachment in CMV Retinitis; Immune Recovery Uveitis; Conclusion; References; 6 Herpes Simplex and Herpes Zoster; Anterior Segment Disease; Herpes Simplex Virus; Treatment; Varicella Zoster Virus; Treatment; Posterior Segment Disease; Acute Retinal Necrosis; Clinical Presentation; Treatment; Progressive Outer Retinal Necrosis; Clinical Presentation; Treatment Options
IndicationsLaser Therapy; Surgery; Steroids; Anti-VEGF Agents; Prognosis; Prevention; Conclusion; References; 11 Rubella; Introduction; Epidemiology; Clinical Manifestations; Diagnosis; Treatment; Conclusion; References; 12 Syphilis; Introduction/Clinical Features; Epidemiology; Diagnostic Evaluation; Treatment and Monitoring; Prognosis; References; 13 Ocular Toxocariasis; Introduction; Epidemiology; Clinical Manifestations; Diagnosis; Treatment; Conclusion; References; 14 Ocular Toxoplasmosis; Introduction; Etiology; Epidemiology; Clinical Presentation